Featured Article

Diabetes and Coronary Artery Disease PowerPoint Presentation • bold tips

Heather Aug 05, 2026

Overview of Diabetes And Coronary Artery Disease Powerpoint Presentation

Diabetes and Coronary Artery Disease PowerPoint Presentation
Diabetes and Coronary Artery Disease PowerPoint Presentation

Learn about screening for diabetes , target-oriented treatment, impact on macrovascular complications, and choosing medications based on cardiac and renal status to reduce cardiovascular risk. Understand the safety warnings and potential side effects of GLP-1 receptor agonists and SGLT-2 inhibitors.

GLP 1 Receptor Agonists and Kidney Protection
GLP 1 Receptor Agonists and Kidney Protection

Slide 3- 1. National Institute of Diabetes & Digestive and Kidney Diseases (NIDDK] Cardiovascular disease is the leading cause of death among many people with diabetes , yet much of the population remains unaware of the risk. 75% of people with diabetes will have heart disease Types of Heart disease include: Coronary artery disease .

CARDIOVASCULAR DISEASE AND DIABETES

SGLT2 Inhibitors and GLP 1 Receptor Agonists in Kidney Transplantation
SGLT2 Inhibitors and GLP 1 Receptor Agonists in Kidney Transplantation

The document discusses the relationship between diabetes mellitus and cardiovascular disease , highlighting the significant increase in the prevalence of diabetes over the past decades and its associated risk factors for cardiovascular disease . It notes that individuals with diabetes face a two to four times higher risk of developing coronary artery disease , along with increased mortality rates ...

Cardiovascular Complications in Diabetes Heart Failure and Diabetic Cardiomyopathy Coronary Artery Disease • Explore the connection between diabetes and heart failure, emphasizing the concept of diabetic cardiomyopathy. • Discuss how diabetes can directly affect the structure and function of the heart.

Cardiovascular Effects of GLP 1 Receptor Agonists
Cardiovascular Effects of GLP 1 Receptor Agonists

Useful Notes on Diabetes And Coronary Artery Disease Powerpoint Presentation

Download Presentation " Diabetes and Coronary Artery " is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.

The best treatment for coronary artery disease in diabetes mellitus is prevention. Prevention at any stage in the natural history of the disease (primordial, primary, secondary, tertiary, quaternary) is exceedingly important to contain the emerging epidemic of diabetes mellitus and coronary artery disease .

PDF GLP 1 receptor agonists impact on cardio renal outcomes
PDF GLP 1 receptor agonists impact on cardio renal outcomes

TCT 257

TCT 257: Impact of Diabetes on Coronary Artery Disease Patterns and PCI Outcomes Presenter: Koshiro Sakai REGISTER for free or LOG IN to view this content Coronary

Download the slide sets (ppt) NEW! 2025 VHD Myocarditis and Pericarditis CVD and Pregnancy Mental Health and CVD FU on Dyslipidaemias 2024 Atrial Fibrillation Chronic Coronary Syndromes (CCS) Elevated Blood Pressure and Hypertension Peripheral Arterial and Aortic Diseases (PAAD) 2023 ACS Cardiomyopathies CVD and diabetes Endocarditis 2022 ...

GLP 1 Receptor Agonists in the Treatment of Patients with Type 2
GLP 1 Receptor Agonists in the Treatment of Patients with Type 2

PPT Coronary Artery Disease

Also associated with progression are generation of thrombin-antithrombin (TAT) complexes, activation and aggregation of platelets, and , ultimately, complete occlusion of the culprit coronary artery . Higher mortality rates are related to the increased size of myocardial damage and greater diminution of coronary blood flow in patients with Q-wave ...

Frontiers
Frontiers
What is GLP 1 and Its Receptor Agonists BOC Sciences
What is GLP 1 and Its Receptor Agonists BOC Sciences
Comparative Effectiveness of Glucagon Like Peptide 1 Receptor Agonists
Comparative Effectiveness of Glucagon Like Peptide 1 Receptor Agonists
GLP 1 Agonist List Types Brands Uses and Key Considerations GLP 1
GLP 1 Agonist List Types Brands Uses and Key Considerations GLP 1
GLP 1 Receptor Agonists The Game Changer in Metabolic and Renal
GLP 1 Receptor Agonists The Game Changer in Metabolic and Renal
Mechanisms by which GLP 1 agonists may exert beneficial effects on
Mechanisms by which GLP 1 agonists may exert beneficial effects on
Renal Effects of GLP 1 Receptor Agonists and Tirzepatide
Renal Effects of GLP 1 Receptor Agonists and Tirzepatide
PDF SGLT2 Inhibitors and GLP 1 Receptor Agonists in Diabetic Kidney
PDF SGLT2 Inhibitors and GLP 1 Receptor Agonists in Diabetic Kidney

More than 65% of deaths in people with diabetes are caused by cardiovascular disease such as heart attacks, which often occur at an earlier age and result in premature death. - Nearly all adults with diabetes have abnormal cholesterol levels and up to 60% have high blood pressure, significantly increasing their risk of heart disease and stroke. - People with diabetes are at least twice as ...